Zynerba Pharmaceuticals
+$0.03 (+0.81%) As of 4:54 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZYNE and other ETFs, options, and stocks.
About ZYNE
Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions.
CEO
Armando Anido
Employees
26
Headquarters
Devon, Pennsylvania
Founded
2007
ZYNE Key Statistics
Market Cap
154.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.86M
High Today
$3.77
Low Today
$3.72
Open Price
$3.75
Volume
127.75K
52 Week High
$9.00
52 Week Low
$3.15
Analyst Ratings
67%
of 6 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
ZYNE Earnings
-$0.78
-$0.52
-$0.26
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market